Gene · 382
Papers3,632
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,632
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of neurogenic contractions in renal arteries and of cholinergic contractions in coronary arteries by the presumed inhibitor of ADP-ribosylation factor 6, NAV2729. | Naunyn Schmiedebergs Arch Pharmacol | 2022 | 35141760 | PubTator, text mining | PubMed |
| DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6. | Oncogene | 2022 | 35140331 | PubTator, text mining | PubMed |
| Syntenin-1-mediated small extracellular vesicles promotes cell growth, migration, and angiogenesis by increasing onco-miRNAs secretion in lung cancer cells. | Cell Death Dis | 2022 | 35136055 | PubTator, text mining | PubMed |
| The type 3 secretion effector IpgD promotes S. flexneri dissemination. | PLoS Pathog | 2022 | 35130324 | PubTator, text mining | PubMed |
| Proteomic Changes in the Monolayer and Spheroid Melanoma Cell Models of Acquired Resistance to BRAF and MEK1/2 Inhibitors. | ACS Omega | 2022 | 35128241 | PubTator, text mining | PubMed |
| PSD3 downregulation confers protection against fatty liver disease. | Nat Metab | 2022 | 35102341 | PubTator, text mining | PubMed |
| Host miRNAs-microbiota interactions in gastric cancer. | J Transl Med | 2022 | 35093110 | PubTator, text mining | PubMed |
| Extracellular vesicle PD-L1 in reshaping tumor immune microenvironment: biological function and potential therapy strategies. | Cell Commun Signal | 2022 | 35090497 | PubTator, text mining | PubMed |
| Synaptic Plasticity 101: The Story of the AMPA Receptor for the Brain Stimulation Practitioner. | Neuromodulation | 2022 | 35088731 | PubTator, text mining | PubMed |
| Platelet-HIV: interactions and their implications. | Platelets | 2022 | 35086429 | PubTator, text mining | PubMed |
| Functional In Vitro Assessment of VEGFA/NOTCH2 Signaling Pathway and pRB Proteasomal Degradation and the Clinical Relevance of Mucolipin TRPML2 Overexpression in Glioblastoma Patients. | Int J Mol Sci | 2022 | 35054871 | PubTator, text mining | PubMed |
| Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways. | Cells | 2022 | 35053339 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Mediators of Therapy Resistance in the Breast Cancer Microenvironment. | Biomolecules | 2022 | 35053279 | PubTator, text mining | PubMed |
| Dynamic Intercell Communication between Glioblastoma and Microenvironment through Extracellular Vesicles. | Biomedicines | 2022 | 35052830 | PubTator, text mining | PubMed |
| Artificial-Intelligence-Assisted Discovery of Genetic Factors for Precision Medicine of Antiplatelet Therapy in Diabetic Peripheral Artery Disease. | Biomedicines | 2022 | 35052795 | PubTator, text mining | PubMed |
| Which BMI for Diabetes Patients is Better? From the View of the Adipose Tissue Macrophage-Derived Exosome. | Diabetes Metab Syndr Obes | 2022 | 35046685 | PubTator, text mining | PubMed |
| A comprehensive long-read isoform analysis platform and sequencing resource for breast cancer. | Sci Adv | 2022 | 35044822 | PubTator, text mining | PubMed |
| The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy. | Cancers (Basel) | 2022 | 35008381 | PubTator, text mining | PubMed |
| Comparative proteomic analysis of nuclear and cytoplasmic compartments in human cardiac progenitor cells. | Sci Rep | 2022 | 34997006 | PubTator, text mining | PubMed |
| Astragalus membranaceus (Huangqi) and Rhizoma curcumae (Ezhu) decoction suppresses colorectal cancer via downregulation of Wnt5/β-Catenin signal. | Chin Med | 2022 | 34991661 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/382/papers?page=41